Home
Gujarat Themis Biosyn

Gujarat Themis Biosyn Market Share Analysis for June 2026

Industry: N/A

Domaingtbl.in

Year Founded1981

Employees51 - 200

Annual Revenue$10M - $15M

Gujarat Themis Biosyn

Gujarat Themis Biosyn (including company regionals)

gtbl.in

See more website traffic and engagement information

Gujarat Themis Biosyn Revenue up to June 2026 is 10M - 15M

revenue generated by Gujarat Themis Biosyn top domains

Gujarat Themis Biosyn top domains revenue over 3 years

Revenue for Gujarat Themis Biosyn top domains

gtbl.in10M - 15M

See more with Sales Intelligence

Total visits to Gujarat Themis Biosyn's top domains

Understand Gujarat Themis Biosyn market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

gtbl.in2K

See more with Sales Intelligence

Avg. visit duration in Gujarat Themis Biosyn's top domains

Analyze Gujarat Themis Biosyn engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

gtbl.in00:00:32

See more with Sales Intelligence

Avg. pageviews on Gujarat Themis Biosyn's top domains

See how Gujarat Themis Biosyn keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

gtbl.in2.06

See more with Sales Intelligence

Gujarat Themis Biosyn top competitors by domain

Top similar sites in June 2026, ranked by their affinity

google.co.inCompany NameGoogleEmployees> 10001HQUnited States, California, Mountain ViewAnnual revenue> $1BTotal visits60MComputers Electronics and Technology > Search Engines

Top technologies used by Gujarat Themis Biosyn

These are the website technologies, by industry, used by Gujarat Themis Biosyn top domains

Widget (4)

Twemoji

Advertising (1)

PubMatic

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

More Technologies

2

See all

News & Signals from Gujarat Themis Biosyn

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGujarat Themis Biosyn Limited has earnings of $1.14M.Net profit of Gujarat Themis Biosyn declined 9.25% to Rs 10.89 crore in the quarter ended March 2026 as against Rs 12.00 crore during the previous quarter ended March 2025.

NewsGujarat Themis Biosyn Limited acquires MicroBiopharm Japan Co., Ltd. for $134M.Gujarat Themis Biosyn surged 6.11% to Rs 391.40 after the company announced the acquisition of Japan-based MicroBiopharm Japan Co. (MBJ) for about JPY 21.5 billion, or nearly Rs 1,300 crore.

NewsGujarat Themis Biosyn Limited invests into assets: portfolio of anti-tuberculosis (TB) and anti-infective brands in Paris, France, Western Europe, Europe.Gujarat Themis Biosyn has signed asset purchase agreement to acquire a portfolio of anti-tuberculosis (TB) and anti-infective brands from Sanofi, the French-holding company of the Sanofi group, headquartered in Paris.